1. Signaling Pathways
  2. NF-κB
  3. NF-κB

NF-κB (核因子κB)

Nuclear factor-κB; Nuclear factor-kappaB

NF-κB(活化 B 细胞的核因子 κ 轻链增强子)是一种控制 DNA 转录的蛋白质复合物。NF-κB 存在于几乎所有动物细胞类型中,并参与细胞对压力、细胞因子、自由基、紫外线照射、氧化 LDL 以及细菌或病毒抗原等刺激的反应。NF-κB 在调节对感染的免疫反应中起着关键作用。NF-κB 的错误调节与癌症、炎症和自身免疫性疾病、感染性休克、病毒感染和免疫发育不当有关。NF-κB 还与突触可塑性和记忆过程有关。哺乳动物 NF-κB 家族中有五种蛋白质:NF-κB1、NF-κB2、RelA、RelB、c-Rel。

NF-κB (Nuclear factor kappa-light-chain-enhancer of activated B cells) is a protein complex that controls transcription of DNA. NF-κB is found in almost all animal cell types and is involved in cellular responses to stimuli such as stress, cytokines, free radicals, ultraviolet irradiation, oxidized LDL, and bacterial or viral antigens. NF-κB plays a key role in regulating the immune response to infection. Incorrect regulation of NF-κB has been linked to cancer, inflammatory, and autoimmune diseases, septic shock, viral infection, and improper immune development. NF-κB has also been implicated in processes of synaptic plasticity and memory. There are five proteins in the mammalian NF-κB family: NF-κB1, NF-κB2, RelA, RelB, c-Rel.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-108694R
    γ-Tocotrienol (Standard) Inhibitor
    γ-Tocotrienol (Standard) 是 γ-Tocotrienol 的分析标准品。本产品用于研究及分析应用。γ-Tocotrienol 是维生素 E 的一种活性形式。γ-Tocotrienol 能够作用 NF-κB 和 P-gp 信号通路来逆转乳腺癌细胞多药耐药性 (MDR)。γ-Tocotrienol 也是一种新型的放射性保护剂,可减轻放射性核素靶向治疗时对骨髓的辐射损伤。
    γ-Tocotrienol (Standard)
  • HY-W550315
    Dimethyl diacetyl cystinate Inhibitor
    Dimethyl diacetyl cystinate (DACDM) 是一种强效的 NF-κB 抑制剂。Dimethyl diacetyl cystinate 通过增加细胞内氧化型谷胱甘肽 (GSSG) 的含量来改变细胞内的氧化还原平衡,竞争性地阻止被激活的 NF-κB 与 DNA 的结合,从而抑制如 IL-1κ 等炎症因子的产生。Dimethyl diacetyl cystinate 有望用于 UVB 引发的皮肤炎症及相关氧化应激疾病的研究。
    Dimethyl diacetyl cystinate
  • HY-N8563
    Masticadienonic acid Inhibitor
    Masticadienonic acid 是一种具有口服活性和选择性的 MAPK (p38, ERK, JNK) 和 NF-κB 通路的抑制剂,同时是 Nrf2 通路的激动剂。Masticadienonic acid 减少 TNFα、IL-1β、IL-6 等促炎细胞因子释放,恢复肠道紧密连接蛋白 (ZO-1、occludin) 表达,还能调节肠道菌群。Masticadienonic acid 有望用于炎症性肠病的研究。
    Masticadienonic acid
  • HY-122019
    ABD56
    ABD56 是一种具有诱导破骨细胞凋亡的化合物,具有抑制破骨细胞形成和诱导凋亡的活性。ABD56可抑制破骨细胞形成和诱导凋亡,其机制与抑制NFκB和ERK途径有关。
    ABD56
  • HY-N0492AR
    α-Lipoic Acid sodium (Standard)

    α-硫辛酸钠盐 (Standard)

    Inhibitor
    α-Lipoic Acid (sodium) (Standard)是 α-Lipoic Acid (sodium) 的分析标准品。本产品用于研究及分析应用。α-Lipoic Acid (Thioctic acid) sodium 是一种抗氧化剂,是线粒体酶复合物的重要辅助因子。α-Lipoic Acid sodium 可抑制 NF-κB 依赖性的 HIV-1 LTR 活化。α-Lipoic Ac
    α-Lipoic Acid sodium (Standard)
  • HY-161266
    COX-2/NLRP3-IN-1 Inhibitor
    COX-2/NLRP3-IN-1 (Compound 6k) 是一种 COX-2/NLRP3 抑制剂,对 COX-2IC50 为 1.53 μM。COX-2/NLRP3-IN-1 通过抑制 NF-κB/NLRP3 信号通路发挥抗炎作用。
    COX-2/NLRP3-IN-1
  • HY-152945
    Antiproliferative agent-22 Inhibitor
    Antiproliferative agent-22 (compound 2) 是一种抗癌剂。Antiproliferative agent-22 对 MCF-7、MDA-MB-231 和 MDA-MB-468 细胞具有抗增殖活性,IC50 值分别为 6.2 μM、3.3 μM 和 3.3 μM。
    Antiproliferative agent-22
  • HY-147377
    N-Salicyloyltryptamine Inhibitor
    N-Salicyloyltryptamine 是一种电压依赖性离子通道抑制剂,包括 Na+、Ca2+、K+ 通道。N-Salicyloyltryptamine 抑制 K+ 电流的 IC50 为 34.6 μM (Ito)。N-Salicyloyltryptamine 还具有抗惊厥、抗炎、镇痛,和血管舒张的作用。
    N-Salicyloyltryptamine
  • HY-170218
    NLRP3-IN-76 Inhibitor
    NLRP3-IN-76 是一种具有口服活性的 NLRP3 抑制剂。NLRP3-IN-76 可抑制 NO 的产生以及促炎细胞因子(iNOSIL-6IL-1βTNFα) 的 mRNA 水平。NLRP3-IN-76 通过抑制 NLRP3 炎症小体和 NF-κB 信号通路的激活发挥抗炎作用。NLRP3-IN-76 可改善 DSS (HY-116282C) 诱发的结肠炎,并可用于炎症性肠病 (IBD) 的研究。
    NLRP3-IN-76
  • HY-RS09255
    Nfkb1 Mouse Pre-designed siRNA Set A Inhibitor
    Nfkb1 Mouse Pre-designed siRNA Set A 包括针对 Nfkb1 (Mouse) 基因的不同区域设计三对 siRNA,以及阴性对照、FAM 标记阴性对照和阳性对照。
    Nfkb1 Mouse Pre-designed siRNA Set A
  • HY-116145
    MHY884 Inhibitor
    MHY884 是一种酪氨酸酶 (tyrosinase) 抑制剂,通过下调氧化应激来抑制 UVB 诱导的 NF-κB 信号通路的活化。MHY884 抑制黑色素瘤细胞中的氧化应激,并减轻辐射小鼠中 UVB 引起的氧化应激,从而降低 NF-κB 活性。MHY884 有望用于 UVB 诱导的皮肤损伤方面的研究。
    MHY884
  • HY-172871
    Anti-inflammatory agent 102 Inhibitor
    Anti-inflammatory agent 102 (Compound 11a) 是口服有效的抗炎剂。Anti-inflammatory agent 102 通过阻断 ASK1/p38 MAPKs/NF-κB 信号通路的激活来发挥抗炎作用。Anti-inflammatory agent 102 具有显著的抗炎活性,能够抑制 NO、ROS 以及炎症因子 (如IL-6、TNF-α、IL-1β) 的释放。Anti-inflammatory agent 102 可用于溃疡性结肠炎 (UC) 等炎症性疾病的研究。
    Anti-inflammatory agent 102
  • HY-163778
    ZM600 Inhibitor
    ZM600 是一种有效和具有口服活性的抗肝纤维化剂。ZM600 可降低 collagen I、α-SM、p-p65 的蛋白表达。ZM600 具有用于肝纤维化研究的潜力。
    ZM600
  • HY-N0250R
    Saikosaponin D (Standard)

    柴胡皂苷D (Standard)

    Inhibitor
    Saikosaponin D (Standard) 是 Saikosaponin D 的分析标准品。本产品用于研究及分析应用。Saikosaponin D 是从柴胡中分离到的三萜皂苷类,具有抗炎,抗菌,抗肿瘤,抗过敏的功效;Saikosaponin D 可以抑制 selectinSTAT3NF-kB 的活性,活化 estrogen receptor-β
    Saikosaponin D (Standard)
  • HY-176426
    Subquinocin Activator
    Subquinocin 是一种 CYLD 抑制剂,可抑制 USP 家族的去泛素化酶 (DUB)。Subquinocin 通过抑制 CYLD 增强 NF-κBIFN 通路的激活。Subquinocin 促进 RIG-I 介导的干扰素通路中 IRF3 和/或 IRF7 的激活。
    Subquinocin
  • HY-168482
    NF-κB/MAPK-IN-2 Inhibitor
    NF-κB/MAPK-IN-2 (compound 14) 是一种有效的 NF-κBMAPK 抑制剂。NF-κB/MAPK-IN-2 降低 p-p65、p-IκB、p-p38、p-JNK 和 p-ERK 的蛋白表达。NF-κB/MAPK-IN-2 减少 LPS 诱导的 TNF-α 和 IL-6 释放。NF-κB/MAPK-IN-2 抑制 p65 和 c-Fos 的核易位。NF-κB/MAPK-IN-2 具有研究脓毒症的潜力。
    NF-κB/MAPK-IN-2
  • HY-15122AR
    Sinomenine hydrochloride (Standard)

    盐酸青藤碱 (Standard)

    Inhibitor
    Sinomenine hydrochloride (Standard) 是 Sinomenine hydrochloride 的分析标准品。本产品用于研究及分析应用。Sinomenine hydrochloride (Cucoline hydrochloride) 是来自 Sinomenium acutum 的一种生物碱,是 NF-κB 活化的阻断剂。Sinomenine 也是 μ 阿片受体 (μ-opioid receptor) 激活剂。
    Sinomenine hydrochloride (Standard)
  • HY-N0392R
    Polygalasaponin F (Standard)

    瓜子金皂苷己 (Standard)

    Inhibitor
    Polygalasaponin F (Standard) 是 Polygalasaponin F 的分析标准品。本产品用于研究及分析应用。Polygalasaponin F 是一种从 Polygala japonica 提取的齐墩果烷型三萜皂苷,可降低炎性细胞因子肿瘤坏死因子 α (TNFa) 的释放。 Polygalasaponin F 通过调节 TLR4-PI3K/AKT-NF-kB 信号通路减少神经炎症细胞因子的分泌。
    Polygalasaponin F (Standard)
  • HY-N8719
    Pratol

    7-羟基-4'-甲氧基黄酮

    Inhibitor
    Pratol 是有效的 NF-κB 抑制剂。Pratol 显著降低了 LPS 刺激的 RAW 264.7 细胞中 NO 和前列腺素 PGE2 的产生,且无细胞毒性。Pratol 能减少促炎细胞因子。Pratol 可用于炎性疾病和癌症的研究。
    Pratol
  • HY-N1500S1
    Pulegone-d8

    胡薄荷酮-d8

    Inhibitor
    Pulegone-d8 是氘代标记的 Pulegone (HY-N1500)。TPulegone 是一种广泛存在于多种植物精油中的单萜酮类化合物,也可作为鸟类驱避剂。Pulegone 具有抗炎、抗菌、抗真菌和抗痛觉过敏等多种活性。Pulegone 对沙门氏菌属细菌效果显著。
    Pulegone-d<sub>8</sub>
目录号 产品名 / 同用名 应用 反应物种

NF-κB transcription factors are critical regulators of immunity, stress responses, apoptosis and differentiation. In mammals, there are five members of the transcription factor NF-κB family: RELA (p65), RELB and c-REL, and the precursor proteins NF-κB1 (p105) and NF-κB2 (p100), which are processed into p50 and p52, respectively. NF-κB transcription factors bind as dimers to κB sites in promoters and enhancers of a variety of genes and induce or repress transcription. NF-κB activation occurs via two major signaling pathways: the canonical and the non-canonical NF-κB signaling pathways[1]

 

The canonical NF-κB pathway is triggered by signals from a large variety of immune receptors, such as TNFR, TLR, and IL-1R, which activate TAK1. TAK1 then activates IκB kinase (IKK) complex, composed of catalytic (IKKα and IKKβ) and regulatory (NEMO) subunits, via phosphorylation of IKKβ. Upon stimulation, the IKK complex, largely through IKKβ, phosphorylates members of the inhibitor of κB (IκB) family, such as IκBα and the IκB-like molecule p105, which sequester NF-κB members in the cytoplasm. IκBα associates with dimers of p50 and members of the REL family (RELA or c-REL), whereas p105 associates with p50 or REL (RELA or c-REL). Upon phosphorylation by IKK, IκBα and p105 are degradated in the proteasome, resulting in the nuclear translocation of canonical NF-κB family members, which bind to specific DNA elements, in the form of various dimeric complexes, including RELA-p50, c-REL-p50, and p50-p50. Atypical, IKK-independent pathways of NF-κB induction also provide mechanisms to integrate parallel signaling pathways to increase NF-κB activity, such as hypoxia, UV and genotoxic stress.

 

The non-canonical NF-κB pathway is induced by certain TNF superfamily members, such as CD40L, BAFF and lymphotoxin-β (LT-β), which stimulates the recruitment of TRAF2, TRAF3, cIAP1/2 to the receptor complex. Activated cIAP mediates K48 ubiquitylation and proteasomal degradation of TRAF3, resulting in stabilization and accumulation of the NFκB-inducing kinase (NIK). NIK phosphorylates and activates IKKα, which in turn phosphorylates p100, triggering p100 processing, and leading to the generation of p52 and the nuclear translocation of p52 and RELB[2][3].

 

Reference:

[1]. Oeckinghaus A, et al. The NF-kappaB family of transcription factors and its regulation.Cold Spring Harb Perspect Biol. 2009 Oct;1(4):a000034. 
[2]. Taniguchi K, et al. NF-κB, inflammation, immunity and cancer: coming of age. Nat Rev Immunol. 2018 May;18(5):309-324.
[3]. Perkins ND,et al. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol. 2007 Jan;8(1):49-62.

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.